Skip to main content Skip to search Skip to main navigation

Foldable bag

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

Product Information

The small package contains a voluminous bag with long handles. After use, simply fold the bag back up again. 

The cover is integrated into the bag. The package is light and small and even fits in your pocket. 

When unfolded, the bag measures approx. 40 x 40 cm. Environmentally friendly material: The rPET material is made from recycled PET, e.g., from soft drink bottles. 

Please note that due to seasonal factors, delivery of this item may take approximately 2 to 3 weeks. 

Do you Have any Questions?

Ansprechpartner beim GMP-Verlag

Talk to our customer advisors

Do you have any questions about our products and services? We are here to help.

Customer Reviews

0 reviews

Average rating of 0 out of 5 stars

Leave a review!

Share your experiences with other customers.

You may Also be Interested in the Following Products

Skip product gallery

g

Parking disc

Parking disc

Very sturdy parking disc, made of hard plastic, with ice scraper and rubber lip, 3 plastic coins for shopping carts, removable tire tread depth gauge on the back. The parking disc complies with the StVO (German Road Traffic Regulations). Please note that due to seasonal factors, delivery of this item may take approximately 2 to 3 weeks.

delivery time appr. 2-5 workdays after receipt of payment
€5.00 net excl. VAT
Microfiber Cloth

Microfiber Cloth

Now you have the right GMP insight. Soft microfiber cloth printed with GMP-related motifs. Suitable for cleaning glasses, monitors, and mobile device displays. Easy to use: 24.5 cm x 24.5 cm in size. Please note that due to seasonal factors, delivery of this item may take approximately 2 to 3 weeks.

delivery time appr. 2-5 workdays after receipt of payment
€5.00 net excl. VAT

Recommended Articles

Question of the Week | GMP-Verlag

Why is it Important to use Consistent Microbiological Air Monitoring Methods in Pharmaceutical Cleanrooms?

Here's the answer:
Read more
Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Cleaning Validation: When PDE Reports and the Worst-Case Selection do not Align

Robust PDE reports form the basis of risk-based cleaning validation. This article highlights common deficiencies identified during GMP inspections and explains how they can be avoided.

Read more
News: Europe

EDQM: New Working Party on 3D-printed Medicinal Products

The European Pharmacopoeia Commission (EPC) approved the creation of a working party on 3D-printed medicinal products. Its aim is to support the development of appropriate quality standards in the European Pharmacopoeia (Ph. Eur.).
Read more
EMA: 14 New Nitrosamines for Appendix 1

EMA: 14 New Nitrosamines for Appendix 1

Appendix 1 of EMA’s Questions and Answers on nitrosamine impurities has been updated. This appendix contains acceptable intakes (AIs) established for N-nitrosamines.
Read more
WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO: Draft Revision of its Guidelines on Quality Risk Management

WHO published a revised draft of its “WHO guidelines on quality risk management”. Working document QAS/26.994 is open for public comment until 15 November 2026.
Read more
News: Artificial Intelligence

Annex 22: Results of the EMA Workshop

On 30 June, the EMA’s Annex 22 Working Group discussed the future scope of the annex with AI experts and representatives of the pharmaceutical industry (as previously reported).
Read more
News: Artificial Intelligence

EMA Workshop Regarding Annex 22 "Artifical Intelligence"

The current draft of Annex 22, "Artificial Intelligence", proposes excluding generative AI and large language models (LLMs), as well as probabilistic, dynamic and adaptive AI models, from critical GMP applications. Numerous comments submitted during the public consultation challenged this approach. Instead, the aim should be to support innovation and encourage investment by the pharmaceutical industry.
Read more
Question of the Week | GMP-Verlag

What are the Benefits and Limitations of Passive Temperature-Controlled Containers for Drug Transport?

Here's the answer:
Read more
Outsourced Activities in the GDP Environment Part II: Contractual Agreements

Outsourced Activities in the GDP Environment Part II: Contractual Agreements

When outsourcing GDP activities, there is a need for concrete delimitation of responsibilities between a client and a contractor. Read more about the goals and the contents of a quality agreement in the following excerpt from GMP:KnowHow Pharmalogistics (GDP).

Read more
FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

FDA: Adjustment of Nitrosamine Limits for Short-Term Use Medicines

The FDA has updated its recommendations on Acceptable Intake (AI) limits for nitrosamine impurities. Under certain conditions, the Agency now accepts a Less-Than-Lifetime (LTL) adjustment of AI limits for medicinal products that are not intended for lifetime use. This also represents an alignment with the LTL concept of ICH M7(R2).
Read more
Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

Swissmedic: SMS Registration Becomes Prerequisite for GMP Certificates

As of 15 November 2026, active substances must be registered in the EMA's Substance Management Services (SMS) database before Swissmedic can include them in establishment licences and GMP certificates for active substance manufacturers. The new requirement results from modifications to the EudraGMDP database.
Read more
News: EMA

EMA: New Q&As for Biological Medicinal Products

The EMA has added a new section to its Q&As on biological medicinal products addressing medicinal products containing secretomes or extracellular vesicles (EVs) obtained from human or animal cells.
Read more
Previous
Next